Novel frameworks as a source of high-affinity ligands (Q31972135)

5 July 2017

1 reference

title

Novel frameworks as a source of high-affinity ligands (English)

1 reference

5 July 2017

Ladner RC

1

1 reference

5 July 2017

Ley AC

series ordinal

2

1 reference

5 July 2017

publication date

1 August 2001

1 reference

Current Opinion in Biotechnology

5 July 2017

published in

1 reference

5 July 2017

volume

12

1 reference

5 July 2017

issue

4

1 reference

5 July 2017

page(s)

406-410

1 reference

Phage display in pharmaceutical biotechnology

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Natural and designer binding sites made by phage display technology

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Bacterial cell surface display of an enzyme library for selective screening of improved cellulase variants

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Directed evolution of a stable scaffold for T-cell receptor engineering.

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

In vitro selection of functional nucleic acids

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Adaptive recognition by nucleic acid aptamers

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Delineation of a linear epitope by multiple peptide synthesis and phage display

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Binding to protein targets of peptidic leads discovered by phage display: crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Improving SH3 domain ligand selectivity using a non-natural scaffold

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

1 reference

7 January 2021

SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family.

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

M13 bacteriophage displaying disulfide-constrained microproteins

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Peptide exosite inhibitors of factor VIIa as anticoagulants

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Lipocalins as a scaffold

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold.

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Anticalins versus antibodies: made-to-order binding proteins for small molecules

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Engineering Microprotein Ligands for Large–Scale Affinity Purification

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1M and taq DNA polymerase

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Alpha-amylase inhibitors selected from a combinatorial library of a cellulose binding domain scaffold

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Solution structure of the major alpha-amylase inhibitor of the crop plant amaranth

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Specific inhibition of insect alpha-amylases: yellow meal worm alpha-amylase in complex with the amaranth alpha-amylase inhibitor at 2.0 A resolution

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Potent and Selective Kunitz Domain Inhibitors of Plasma Kallikrein Designed by Phage Display

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Iterative optimization of high-affinity proteases inhibitors using phage display. 1. Plasmin

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

The lipocalin protein family: structure and function

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

Design and application of diabodies, triabodies and tetrabodies for cancer targeting

1 reference

https://api.crossref.org/works/10.1016/S0958-1669(00)00235-4

7 January 2021

10.1016/S0958-1669(00)00235-4

Identifiers

DOI

1 reference

5 July 2017

1 reference